Crystalys Therapeutics: Funding, Investors & Team (Sep 2026)
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Crystalys Therapeutics has raised $335M across 2 funding rounds on record, the most recent a Series B of $130M announced in Jul 2026.
That round is above the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Crystalys Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Crystalys Therapeutics Funding Rounds
Crystalys Therapeutics raised $205M in a Series A announced in Oct 2025.
9 months later, a Series B of $130M was announced in Jul 2026.
Crystalys Therapeutics Investors
21 investors are recorded in total; the 5 named above are those the record identifies.
Crystalys Therapeutics Founders and Leadership Team
Contact details for the Crystalys Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Crystalys Therapeutics Funding Compared to Other Biotechnology Startups
Crystalys Therapeutics' latest round of $130M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Crystalys Therapeutics in Biotechnology and San Diego
Companies Similar to Crystalys Therapeutics
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease…
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
Crystalys Therapeutics Funding FAQs
What does Crystalys Therapeutics do?
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
How much funding has Crystalys Therapeutics raised?
Crystalys Therapeutics has raised $335M across 2 rounds on record. The most recent is a Series B of $130M announced in Jul 2026.
When did Crystalys Therapeutics last raise funding?
Crystalys Therapeutics' most recent funding round on record is a Series B of $130M, announced in Jul 2026.
Who has invested in Crystalys Therapeutics?
Investors on record for Crystalys Therapeutics include Wellington Management, Cormorant Asset Management, SR One, Frazier Life Sciences, Novo Holdings. FundedIQ records 21 investors in total.
Who founded Crystalys Therapeutics?
FundedIQ lists Ashwin Ram (Co-Founder and Chief Operating Officer) at Crystalys Therapeutics.
Who is the CEO of Crystalys Therapeutics?
James Mackay, Ph.D. is listed as CEO at Crystalys Therapeutics.
Where is Crystalys Therapeutics headquartered?
Crystalys Therapeutics is based in San Diego, United States.
How many employees does Crystalys Therapeutics have?
Crystalys Therapeutics is in the 11-50 employee band.
When was Crystalys Therapeutics founded?
Crystalys Therapeutics was founded in 2025.
How does Crystalys Therapeutics' funding compare to other Biotechnology startups?
Crystalys Therapeutics' latest round of $130M is above the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's Crystalys Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Crystalys Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.